U.S. Court of Appeals for the Federal Circuit, 2025

Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited

Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited
U.S. Court of Appeals for the Federal Circuit · Decided November 5, 2025

Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited

Opinion

Case: 24-1606 Document: 49 Page: 1 Filed: 11/05/2025

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ SUPERNUS PHARMACEUTICALS, INC., Plaintiff-Appellee v. AJANTA PHARMA LIMITED, AJANTA PHARMA USA INC., Defendants TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LTD., Defendants-Appellants ______________________ 2024-1606 ______________________ Appeal from the United States District Court for the District of New Jersey in Nos. 3:21-cv-06964-GC-DEA, 3:21-cv-14268-GC-DEA, Judge Georgette Castner. ______________________ ORDER The parties, having so agreed, IT IS ORDERED THAT: Case: 24-1606 Document: 49 Page: 2 Filed: 11/05/2025

2 SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED

The above-captioned appeal is dismissed under Fed. R. App. P. 42(b) with each side to bear their own costs.

FOR THE COURT

November 5, 2025 Date

ISSUED AS A MANDATE: November 5, 2025

Case-law data current through December 31, 2025. Source: CourtListener bulk data.